ArticleDermatology and therapyPublished
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Dermatology and therapy
- Published
- Topic
- Clinical care
- Subject terms
- Safety; Pharmacokinetics; Psoriasis; Chinese Subjects; Deucravacitinib; Tyrosine Kinase 2 Inhibitor
- PubMed ID
- 37981596
- PubMed Central ID
- PMC10689320
- Open access
- Yes, open
- Added to directory
- Source checked